Cargando…
Anti-CD133 Antibody Immobilized on the Surface of Stents Enhances Endothelialization
Drug eluting stents successfully reduce restenosis at the cost of delayed reendothelialization. In recent years, a novel concept to enhance reendothelialization using anti-CD34 antibody coated stents which capture circulating progenitor cells (EPCs) has been developed with conflicting clinical resul...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966336/ https://www.ncbi.nlm.nih.gov/pubmed/24734251 http://dx.doi.org/10.1155/2014/902782 |